InvestLog
SION Sionna Therapeutics, Inc. logo

SION Sionna Therapeutics, Inc.

Healthcare
$41.13-1.49%ClosedMarket Cap: $1.86B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

6.41

P/S

0.00

EV/EBITDA

-20.34

DCF Value

$1.23

FCF Yield

-3.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-27.3%

ROA

-28.1%

ROIC

-33.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-26.8M$—
Q4 null$0.00$-20.4M$—
FY null$0.00$-75.3M$—
Q3 null$0.00$-20.3M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$48.00

Target (Median)

$53.00

Target Range

$24.00 - $58.00

1 Strong Buy9 Buy1 Hold0 Sell1 Strong Sell
Freedom BrokerHold
2026-05-20
StifelBuy
2026-05-18
BTIGBuy
2026-05-13
Jones TradingBuy
2026-04-28
GuggenheimBuy
2026-03-03

Trading Activity

Insider Trades

View All
Thompson Peter A.director
SellMon May 11
Thompson Peter A.director
SellMon May 11
Thompson Peter A.director
SellMon May 11
ORBIMED ADVISORS LLCdirector
SellMon May 11
ORBIMED ADVISORS LLCdirector
SellMon May 11

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

1.34

Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Peers

ABCL logoABCLARDX logoARDXBHVN logoBHVNCLDX logoCLDXIMNM logoIMNMJANX logoJANXMAZE logoMAZEVERA logoVERAXERS logoXERSZYME logoZYME